We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$286M
AUM Growth
+$5.92M
Cap. Flow
-$3.16M
Cap. Flow %
-1.1%
Top 10 Hldgs %
33.2%
Holding
86
New
7
Increased
16
Reduced
47
Closed
2

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$707K
2
CYCN icon
Cyclerion Therapeutics
CYCN
+$466K
3
AMZN icon
Amazon
AMZN
+$443K
4
BDX icon
Becton Dickinson
BDX
+$352K
5
DOW icon
Dow Inc
DOW
+$340K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$871K
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$716K
3
DD icon
DuPont de Nemours
DD
+$670K
4
MA icon
Mastercard
MA
+$504K
5
ORCL icon
Oracle
ORCL
+$372K

Sector Composition

Rank Sector Weight
1 Healthcare 21.99%
2 Technology 20.32%
3 Industrials 14.23%
4 Financials 8.24%
5 Consumer Staples 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMB icon
51
Kimberly-Clark
KMB
$36B
$537K 0.19%
4,030
– –
IBM icon
52
IBM
IBM
$200B
$524K 0.18%
3,971
-26
-0.7% -$3.42K
CAT icon
53
Caterpillar
CAT
$398B
$522K 0.18%
3,834
-40
-1% -$5.29K
GE icon
54
GE Aerospace
GE
$354B
$520K 0.18%
9,972
-1,206
-11% -$59.4K
CI icon
55
Cigna
CI
$75.1B
$504K 0.18%
3,200
-185
-5% -$29K
CYCN icon
56
Cyclerion Therapeutics
CYCN
$15.8M
$377K 0.13%
+1,646
New +$466K
BDX icon
57
Becton Dickinson
BDX
$42.6B
$372K 0.13%
+1,516
New +$352K
COP icon
58
ConocoPhillips
COP
$141B
$362K 0.13%
5,938
– –
BAX icon
59
Baxter International
BAX
$11.4B
$361K 0.13%
4,413
-100
-2% -$7.76K
DD icon
60
DuPont de Nemours
DD
$18.3B
$333K 0.12%
3,536
-5,613
-61% -$670K
TMO icon
61
Thermo Fisher Scientific
TMO
$196B
$333K 0.12%
1,135
-21
-2% -$5.78K
DOW icon
62
Dow Inc
DOW
$21.9B
$318K 0.11%
+6,439
New +$340K
CSX icon
63
CSX Corp
CSX
$93.1B
$317K 0.11%
12,300
-300
-2% -$7.73K
PSX icon
64
Phillips 66
PSX
$83.7B
$286K 0.1%
3,065
-62
-2% -$5.56K
NEE icon
65
NextEra Energy
NEE
$184B
$284K 0.1%
5,560
– –
BKH icon
66
Black Hills Corp
BKH
$5.67B
$272K 0.1%
3,474
– –
PFE icon
67
Pfizer
PFE
$141B
$252K 0.09%
6,113
-369
-6% -$14.7K
NVO
68
Novo Nordisk
NVO
$219B
$248K 0.09%
9,750
-230
-2% -$5.68K
EMR icon
69
Emerson Electric
EMR
$76.5B
$237K 0.08%
3,558
+100
+3% +$6.7K
LLY icon
70
Eli Lilly
LLY
$1.02T
$228K 0.08%
2,057
-225
-10% -$26.5K
CXT icon
71
Crane NXT
CXT
$2.94B
$225K 0.08%
7,776
– –
DE icon
72
Deere & Co
DE
$158B
$211K 0.07%
1,280
– –
JPM icon
73
JPMorgan Chase
JPM
$901B
$207K 0.07%
+1,848
New +$204K
SJM icon
74
J.M. Smucker
SJM
$12B
$202K 0.07%
1,756
-886
-34% -$108K
TRV icon
75
Travelers Companies
TRV
$78.4B
$202K 0.07%
+1,350
New +$195K
1 2
3
4

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q2 2019 Portfolio in Review

As of Q2 2019, Brian C. Broderick held 86 positions worth $286M, up 2.1% from $280M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick's Q2 2019 filing shows 7 new, 16 increased, 47 reduced and 2 closed positions. Its largest new stake was Alcon: 12,049 shares worth $747K. The largest sale was Novartis, an estimated $871K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick's largest Q2 2019 buy was Alcon: 12,049 shares worth $747K.
  • Brian C. Broderick added most to Amazon in Q2 2019, an estimated $443K increase.
  • Brian C. Broderick's biggest Q2 2019 reduction was Novartis, cutting an estimated $871K.
  • Brian C. Broderick fully exited Altria Group in Q2 2019, selling an estimated $216K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $286M portfolio in Q2 2019.
  • Brian C. Broderick opened 7 new positions and closed 2 in Q2 2019.
  • Brian C. Broderick's portfolio value rose 2.1% quarter-over-quarter to $286M.

Based on Brian C. Broderick's 13F filing for Q2 2019, filed 24 Jul 2019.